Those crazy kids are at it again.

Another med school is about to implement a policy to limit drug reps at the urging of some of its students. This time, it’s the University of Toledo, which plans to….

• Ban all gifts, including pens and lunches;
• Make sure a faculty member is present while drug rep talks with students;
• Limit companies to giving unrestricted grants, which could be used for lunches;
• Teach students and residents more about dealing with reps and assessing clinical trials;
• Have reps register with the medical center and take a two-hour class on relations with students and residents.

“You have to constantly be considering what you’re doing to make sure everything you do is always in the best interest of your patients,” fourth-year student Mary LaSalvia (pictured) tells The Toledo Blade. You have to constantly be considering what you’re doing to make sure everything you do is always in the best interest of your patients.”

The move comes shortly after the American Medical Student Association released its first-ever scorecard of med schools to see which ones meet the group’s standards for keeping a healthy distance from big pharma’s sales reps. The ranking is based on school policies. A poor grade prompted UCLA’s med school to promote its own plan to institute tougher rules.

Of course, there could be retaliation. Jeff Gold, dean of UT’s College of Medicine, says drugmakers could decide to not award research grants to UT because of the policy, although he labels that a small concern because they need such expertise to develop products.

John Billi, associate vice president for medical affairs at the University of Michigan at Ann Arbor, one of only a handful of schools to receive an ‘A’ from the AMSA, says drugmakers aren’t likely to pull research funding. “These companies aren’t stupid or spiteful.”